Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06152276

SafeHeal Diverting Ileostomy Pivotal Study

SafeHeal Diverting Ileostomy Pivotal Study (SH-SOC23)

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
132 (actual)
Sponsor
SafeHeal Inc · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This SafeHeal study is designed to assess the overall safety of the low anterior resection (LAR) standard of care cancer treatment by establishing a definition of major complications. The current literature on standard of care reports adverse events/complications but does not provide a single endpoint that can be used to compare the safety of LAR cancer treatment to alternative therapies or treatments. This study will allow for the establishment of a new single safety endpoint for LAR standard of care cancer treatment.

Detailed description

This SafeHeal study is designed to assess the overall safety of the low anterior resection (LAR) standard of care cancer treatment by establishing a definition of major complications. The current literature on standard of care reports adverse events/complications but does not provide a single endpoint that can be used to compare the safety of LAR cancer treatment to alternative therapies or treatments. This study will allow for the establishment of a new single safety endpoint for LAR standard of care cancer treatment. The data from this study could serve as the historical control arm data of a SafeHeal Colovac Colorectal Anastomosis Protection Device Evaluation (SAFE-3) Pivotal Study designed as a prospective, non-randomized, sequential, controlled, multicenter trial comparing the investigational device, the next generation Colovac Anastomosis Protection Device, to the standard of care (SOC), diverting ostomy.

Conditions

Interventions

TypeNameDescription
OTHERDiverting loop ileostomyDiverting loop ileostomy following low anterior resection of colorectal cancer

Timeline

Start date
2024-01-01
Primary completion
2026-02-28
Completion
2026-03-01
First posted
2023-11-30
Last updated
2026-02-18

Locations

3 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT06152276. Inclusion in this directory is not an endorsement.